Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Experimental Neurology
|
July 28, 2012
TNF-α-mediated anxiety in a mouse model of multiple sclerosis
Nabila Haji, Georgia Mandolesi, Antonietta Gentile, et al.
Parkinsonism & Related Disorders
|
March 3, 2024
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
Mario Stampanoni Bassi, Luana Gilio, Giovanni Galifi, et al.
Molecular Pharmacology
|
April 29, 2010
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition
Silvia Rossi, Valentina De Chiara, Alessandra Musella, et al.
Expert Opinion on Therapeutic Targets
|
January 5, 2020
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting
Alessandra Musella, Diego Fresegna, Francesca Romana Rizzo, et al.
Brain, Behavior, and Immunity
|
April 9, 2011
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
Silvia Rossi, Roberto Furlan, Valentina De Chiara, et al.
Neurobiology of Disease
|
May 18, 2019
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination
Georgia Mandolesi, Silvia Bullitta, Diego Fresegna, et al.
Neurobiology of Disease
|
December 17, 2014
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis
Antonietta Gentile, Diego Fresegna, Mauro Federici, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
February 2, 2013
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis
Antonietta Gentile, Silvia Rossi, Valeria Studer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis
Silvia Rossi, Fabio Buttari, Valeria Studer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 18, 2010
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum
Valentina De Chiara, Francesco Angelucci, Silvia Rossi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Experimental Neurology
|
July 28, 2012
TNF-α-mediated anxiety in a mouse model of multiple sclerosis
Nabila Haji, Georgia Mandolesi, Antonietta Gentile, et al.
Parkinsonism & Related Disorders
|
March 3, 2024
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
Mario Stampanoni Bassi, Luana Gilio, Giovanni Galifi, et al.
Molecular Pharmacology
|
April 29, 2010
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition
Silvia Rossi, Valentina De Chiara, Alessandra Musella, et al.
Expert Opinion on Therapeutic Targets
|
January 5, 2020
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting
Alessandra Musella, Diego Fresegna, Francesca Romana Rizzo, et al.
Brain, Behavior, and Immunity
|
April 9, 2011
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
Silvia Rossi, Roberto Furlan, Valentina De Chiara, et al.
Neurobiology of Disease
|
May 18, 2019
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination
Georgia Mandolesi, Silvia Bullitta, Diego Fresegna, et al.
Neurobiology of Disease
|
December 17, 2014
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis
Antonietta Gentile, Diego Fresegna, Mauro Federici, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
February 2, 2013
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis
Antonietta Gentile, Silvia Rossi, Valeria Studer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis
Silvia Rossi, Fabio Buttari, Valeria Studer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 18, 2010
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum
Valentina De Chiara, Francesco Angelucci, Silvia Rossi, et al.
Page
of 10